Ufp Technologies (UFPT) Income from Non-Controlling Interests (2010 - 2011)
Ufp Technologies' (UFPT) quarterly Income from Non-Controlling Interests came in at $4601.0 in Q4 2011, down 96.14% on a YoY basis from $119079.0 in Q4 2010, and up 4.21% quarter-over-quarter from $4415.0 in Q3 2011.
Analysis
Ufp Technologies (UFPT) Income from Non-Controlling Interests (2010 - 2011) Analysis & Trends
Ufp Technologies (UFPT) has reported Income from Non-Controlling Interests for 2 consecutive years, with $4601.0 the latest figure, recorded in Q4 2011.
- For the quarter ending Q4 2011, Income from Non-Controlling Interests fell 96.14% year-over-year to $4601.0; the trailing twelve-month figure through Dec 2011 stood at $438000.0 (changed N/A YoY), and the FY2011 full-year result was $438000.0, up 173.02% from the prior year.
- Income from Non-Controlling Interests rose to $4601.0 in Q4 2011 per UFPT's latest filing, from $4415.0 in the prior quarter.
- Across five years, Income from Non-Controlling Interests topped out at $428285.0 in Q1 2011 and bottomed at $699.0 in Q2 2011.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inc. Minority (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 179.79 Bn | 174.18 Bn | 7.27 Bn | - |
| 2 | Intuitive Surgical | 127.69 Bn | 122.47 Bn | 1.96 Bn | 6.60 Mn |
| 3 | Medtronic | 117.23 Bn | 108.41 Bn | 6.34 Bn | 9.00 Mn |
| 4 | Stryker | 103.55 Bn | 100.07 Bn | 4.50 Bn | - |
| 5 | Boston Scientific | 63.24 Bn | 62.70 Bn | 3.85 Bn | -2.00 Mn |
| 6 | Edwards Lifesciences | 49.97 Bn | 45.72 Bn | 1.35 Bn | -500,000.00 |
| 7 | Alcon | 32.83 Bn | 31.37 Bn | 1.68 Bn | - |
| 8 | Dexcom | 32.30 Bn | 30.35 Bn | 830.00 Mn | - |
| 9 | Steris | 20.73 Bn | 20.25 Bn | 684.20 Mn | 900,000.00 |
| 10 | Ufp Technologies | 2.15 Bn | 2.14 Bn | 50.92 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2011 | 4,601.00 |
| Sep 30, 2011 | 4,415.00 |
| Jun 30, 2011 | 699.00 |
| Mar 31, 2011 | 428,285.00 |
| Dec 31, 2010 | 119,079.00 |
| Sep 30, 2010 | 14,554.00 |
| Jun 30, 2010 | 15,729.00 |